Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Karyopharm Therapeutics Inc Announces Pricing Of Initial Public Offering


Tuesday, 5 Nov 2013 08:33pm EST 

Karyopharm Therapeutics Inc announced the pricing of its Initial Public Offering (IPO) of 6,800,000 shares of its common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Karyopharm. In addition, Karyopharm has granted the underwriters a 30-day option to purchase up to an additional 1,020,000 shares of common stock at the same price, less the underwriting discount. The Company's shares are expected to begin trading on the NASDAQ Global Select Market on November 6, 2013 under the ticker symbol KPTI. The offering is expected to close on November 12, 2013. BofA Merrill Lynch and Leerink Swann LLC are acting as joint book-running managers for the offering. JMP Securities LLC and Oppenheimer & Co. are acting as co-managers.